ImmunityBio, Inc. (IBRX)
Market Closed
16 Oct, 08:00 PM
$
9. 18
-0.82
-8.2%
$
9.73B Market Cap
- P/E Ratio
- Div Yield
21.48M Volume
-0.93 Eps
$ 10
Previous Close 
Want to track IBRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ImmunityBio, Inc. (IBRX) Statistics
Valuation metrics
Market Cap 9.73B
Enterprise value 11.75B
Trailing P/E (ttm) -10.79
Forward P/E -403.5
PEG ratio 0.09
Price/Sales (ttm) 66.39
Price/Book (mrq) -10.54
Enterprise Value/Revenue 70.84
Enterprise Value/EBITDA -13.16
Overview
Shares outstanding 1.01B
Float 377.71M
Shares short 135.54M
% Held by insiders 0.64%
% Held by institutions 0.17%
Average volume (10 days) 18.61M
Average volume (90 days) 11.66M
Price summary
52-Week low 1.95
52-Week high 12.43
Beta 0.06
50-Day moving average 8.54
200-Day moving average 7.72
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -5.99%
Operating margin -1.52%
Operational effectiveness
Return on assets -1.58%
Return on equity 1.35%
Income Statement
Revenue (ttm) 113.29M
Revenue per share (ttm) 0.16
Quarterly revenue growth (yoy) 4.07%
Gross profit (ttm) 112.53M
EBITDA -240.6M
Net income to common (ttm) -351.4M
Diluted EPS (ttm) -0.95
Quarterly earnings growth (yoy) 4.07%
Balance Sheet
Total cash (mrq) 242.82M
Total cash per share (mrq) 0.34
Total debt (mrq) 844.72M
Total Debt/Equity (mrq) -0.78
Current ratio (mrq) 5.72%
Book value per share (mrq) -1
Cash Flow
Cash flow statement -304.94M
Levered free cash flow (LFCF) -213.36M
2026 © Marketlog. All Rights Reserved.
